Glenn Giamo

Glenn Giamo has extensive work experience in finance and operations within the pharmaceutical industry. Glenn has held various roles with companies such as SK Life Science, Roivant Sciences, and Vyera Pharmaceuticals. Glenn has experience in budgeting, forecasting, clinical operations finance, and financial planning and analysis. Glenn has also worked as a consultant for organizations like NYU Langone Health and Tufts Center for the Study of Drug Development, where they provided expertise in contract negotiation, site operations, and drug development cost analysis. Prior to their pharmaceutical career, Glenn worked as a senior financial analyst for CNBC and as an internal auditor and business analyst for Sterling Drug Inc./Sanofi Winthrop. Overall, Glenn's expertise lies in financial analysis, controls, and operations in the pharmaceutical industry.

Glenn Giamo holds a Bachelor of Science (BS) degree in Accounting from Seton Hall University. Additionally, they have obtained certifications in "Financial Forecasting with Big Data" from LinkedIn in September 2018 and has passed the Certified Public Accountant (CPA) exam in New York, although the specific details regarding when they obtained this certification are not provided.